technology access to
the poorest sections
of our society at
affordable prices,
to the middle class,
and to those who can
afford higher-end
technologies alike.
Well-meaning policies,
thereby, should factor
in possible long-
term implications,
in order for them to
be comprehensive.
This will not just
pave the way for
universal health for
all, providing impetus
to the ‘Make in India’
vision while generating
more employment
opportunities.
The pace of positive
long-term changes
unfolding in the
country is quite
promising. The terrific
direction that our
strategic foreign affairs
policy has taken,
apparent in the recent
bilateral agreements
signed with Israel gives
hope for more nuanced
and enabling domestic
48
BioVoiceNews | September 2017
policies, especially for
the MedTech sector
which is a fledgling
and relatively nascent
industry beseeching
the right climate for
investments and ease-
of-doing business.
Ensuring this alone
will truly help medical
device companies in
India to prod their
headquarters to
‘make in India’ and
‘make with India’,
as PM Modi and PM
Netanyahu suggested,
for the world.
MADHULIKA V. NARASIMHAN
Madhulika V. Narasimhan is an
independent communications
consultant and a policy commentator
with a passion for writing on public
health, development and governance
issues.